Home » Invitrogen Completes Acquisition of Dynal
Invitrogen Completes Acquisition of Dynal
Invitrogen Corporation announced that it has completed its acquisition of Dynal Biotech. Invitrogen acquired Dynal from majority owner Nordic Capital and a co-investor in a cash transaction totaling approximately 2.5 billion NOK, or approximately $391 million, based on foreign currency forward contracts executed previously by Invitrogen.
Yahoo News (http://biz.yahoo.com/bw/050401/15156.html?.v=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May